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Abstract: The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe
acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known
to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first
diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000
cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug,
isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal
and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell
culture tropism of the virus that will be available to the research communities.
Key words: COVID-19, SARS-CoV-2, coronavirus

1. Introduction
New coronaviruses are likely to occur periodically in
humans, considering the high prevalence and wide
distribution of coronaviruses, the large genetic diversity
and frequent recombination of genomes, common
interspecific infections, and rare outbreaks (Wong et al.,
2015; Cui et al., 2019).The novel coronavirus pneumonia,
which was named later as coronavirus disease 2019
(COVID-19), is caused by the severe acute respiratory
syndrome coronavirus 2, namely SARS-CoV-2 (Holshue
et al., 2020). It is a positive-strand RNA virus (family:
Coronaviridae), showing high homology with SARS-CoV
and bat coronavirus (Zheng 2020; Liu and Li, 2020). SARSCoV-2 is the seventh coronavirus known to infect humans;
SARS-CoV, MERS-CoV, and SARS-CoV-2 can cause
severe disease, whereas HKU1, NL63, OC43, and 229E are
associated with mild symptoms (Andersen et al., 2020).

The novel SARS-CoV-2 is the virus behind the pandemic
outbreak originating from China (Zhou et al., 2020) a large
number of SARS-related coronaviruses (SARSr-CoVs and
this recent coronavirus outbreak (COVID-19) presents
enormous challenges for global health. The first diagnosed
patient in Turkey was announced by the Ministry of
Health on March 11, 2020. Since then, more than 150,000
diagnosed patients have been reported, showing the urgent
need for vaccine studies and antiviral drug discoveries.
Thus, it is important to isolate and propagate SARS-CoV-2
strains from Turkish COVID-19 patients. We isolated the
virus from nasopharyngeal and oropharyngeal specimens.
We characterized replication properties and cell culture
tropism of SARS-CoV-2 in different cell lines including
green monkey kidney cell line (Vero, ATCC CCL-81) and
Madin-Darby bovine kidney cell line (MDBK, ATCC CCL22). This study provides isolation and characterization
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methodology, which enables research communities to
propagate the isolated virus in high-titer for vaccine
development and antiviral drug screening.
2. Methods
2.1. Ethics approval and consent to participate
SARS-CoV-2 isolation and propagation were performed
in Acıbadem Labcell Cellular Therapy Laboratory BSL-3
units within the scope of TÜSEB COVID-19 Virus Vaccine
Development and TÜBİTAK-MAM Coronary Virus
Injection and Drug Development Projects (33352965517-E.98243). Each patient was informed and approved
the patient information and consent form, which is named
“Inactive COVID-19 Vaccine Production”.
2.2. Collection and transportation of specimen
Samples were collected from the nasopharyngeal and
oropharyngeal cavity of COVID-19 positive diagnosed
patients according to their real-time PCR analysis in
Acıbadem Altunizade Hospital, İstanbul. Swabs were put
into the transportation medium and transferred at 4 °C
to Acıbadem Labcell Cellular Therapy Laboratory BSL3 Units on the same day for analysis and propagation.
Transfer medium contains DMEM high glucose (Thermo
Fisher Scientific Inc., Waltham, MA, USA), 2% penicillinstreptomycin solution (Biological Industries, Beit HaEmek,
Israel), and5 µg/mL amphotericin (Bristol Myers Squibb,
New York, NY, USA).
2.3. Virus isolation and propagation
The virus isolation and propagation process was started
with the 96-well plate with a Vero cell line (CCl-81,
ATCC) because of the low virus titer in inoculum samples
(Harcourt et al. 2020). Firstly, Vero cells were trypsinized,
centrifuged and suspended in virus media that is composed
of DMEM high glucose (Thermo Fisher Scientific Inc.),
with 2% fetal bovine serum (Thermo Fisher Scientific
Inc.) and 1% penicillin-streptomycin-amphotericin (PSA)
solution (Pan-Biotech GmbH, Aidenbach, Germany).
Cells were seeded 2.5 × 104 into each well. Then, 100 µL
of inoculum sample was added to the 1st line, and 50 µL
of the virus media added to other wells of the plate. Serial
dilution was done starting from the 1st line to 12th with 50
µL of virus medium (as 1/2 serial dilution) and incubated
at 37 °C. Each day cytopathic effect was recorded under an
inverted microscope (Leica Microsystems GmbH, Wetzlar,
Germany) and after its detection; cells were scraped from
the well and transferred to the 24-well plate with the Vero
cell line in 25 × 104 concentrations per well. The cytopathic
effect was observed and cells transferred to the T75
tissue culture flask. Virus replication and isolation was
detected with observed cytopathic effect and virus isolate
transferred to the T75 tissue culture flask prepared in 5
× 106 concentration. For higher propagation, virus isolate
was transferred to the T300 tissue culture flask. At this

point, the average number of days for cytopathic effect can
be known as 3–4 days.
2.4. Virus identification and characterization
The virus isolate were confirmed through loop-mediated
isothermal amplification (LAMP) assay and transmission
electron microscopy (TEM).
RNA isolation, reverse transcription, and LAMP
assay: Total RNA isolations were carried using Direct-zol
RNA Miniprep Kits (Zymo Research Corp., Tustin, CA,
USA), and concentrations were determined using Qubit
fluorometer with the Qubit RNA HS Assay (Thermo
Fisher Scientific Inc.). cDNA synthesis was performed
using random oligonucleotides. Relative flouresence units
(RFU) was measured every 0.5 degree from 60 degrees
to 95 degrees for the melting curve and this is repeated
graphically by repeating twice. Melting curves are created
by manufacturers preinstalled high-resolution melting
settings of Bio-Rad CFX96. Two LAMP assay reactions
were set-up in CFX96 (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA) for each sample with SARS-CoV-2
LAMP primer mix and internal control LAMP primer mix
(Primers designed by Epigenetiks Genetics Bioinformatics
Software Inc., İstanbul, Turkey). EvaGreen fluorescent dye
(Biotium, Inc., Fremont, CA, USA) was added to each
reaction mixture for real-time LAMP detection. Melt curve
analysis and 1% agarose gel electrophoresis were used for
the evaluation of the results. Here, the virus gene encoding
nucleocapsid (N) protein was used as a target gene in SARSCoV-2 and actin as an internal control. Next, SARS-CoV-2
specific RT-PCR was performed with the LAMP-positive
samples using Bosphore Novel Coronavirus (2019-nCoV)
Detection Kit (Anatolia Geneworks, Anatolia Diagnostics
and Biotechnology Products Inc., İstanbul, Turkey) along
with Orf1ab and E gene primers. The RT-PCR analysis was
performed in Roche LightCycler 96.
Transmission electron microscopy (TEM): Infected
Vero cells were scraped from the flask and centrifuged
at 300XG for 10 min. The cell pellet was rinsed with 0.1
M phosphate buffer saline (Thermo Fisher Scientific
Inc.) centrifuged at 300XG for 10 min. Pellet was fixed
2.5% glutaraldehyde in PBS (0.1 M, pH 7.2) for 2 h, and
then postfixed with 1% osmium tetroxide in PBS (0.1 M,
pH 7.2) for 1 h at room temperature. Pellet was en bloc
stained with 4% uranyl acetate, dehydrated with increasing
concentrations of ethyl alcohol, and embedded in Epon
812 resin. Ultrathin sections of 600 angstroms were
stained with 4% uranyl acetate and lead citrate. Ultrathin
sections were evaluated under a transmission electron
microscope (Thermo Fisher Scientific Inc.-Talos L120C)
and photographed.
CPE assay: CPE test was performed based on general
procedure with small modifications as following. Vero
CCL-81 cells and MDBK CCL-22 cells were seeded
for a 6-well plate (1 × 105 cells/well) and left for 24 h
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incubation at 37 °C. After cell incubation period, virus
sample was serially diluted log10 for virus CPE titration
assay. Cells were washed with cell media (DMEM High,
Thermo Fisher Scientific Inc.) that contain only 1% PSA
(Pan-Biotech GmbH). Virus dilutions were inoculated
to cells in 1 mL volume, left for the 1-h incubation, and
plates were shaken gently in 20 min. In this period, also
cell culture medium that contains 2% agarose and DMEM
cell culture media (2% FBS and 1% PSA) in 1:1 volume
ratio were prepared and put into the 56 °C water bath
for 30 min. After virus inoculation, nonadsorbed viruses
were removed and 1 mL warm CPE medium added on
infected cells. Plates were left under the hood for 15 min
without a cap and then put into 37 °C incubator for 7–10
days. For the determination of the CPE firstly cells were
fixated with 10% of paraformaldehyde for 1 h. Agarose
layers were removed from the well and then 500 µL of
undiluted crystal violet solution was added to each well
and incubated on a shaker for 5–10 min. Crystal violet was
discarded and plates were washed with tap water without
disrupting cell monolayer until the water was clear. Plates
were left on a paper towel till dry. CPE were imaged under
an inverted microscope.
2.5. Immunological response
Inactivation of virus: Infected Vero cells were scraped
from the flask and centrifuged at 1000 rpm for 10 min. The
cell pellet was rinsed with 0.1 M phosphate buffer saline
(Thermo Fisher Scientific Inc.) centrifuged at 1000 rpm for
10 min. Pellet was fixed 2.5% glutaraldehyde (GA) in 0.1
M phosphate buffer saline (PBS) (pH 7.4) for at least 2 h
at room temperature (Harcourt et al. 2020). Virus solution
(15 mL) was added to Amicon Ultra 50,000 KDa NMWL
and centrifuge at 4,000XG for 15 min to wash from excess
GA. For washing sample was diluted with 1mL of PBS and
centrifuge for 15 min at 4,000XG. The sample was diluted
with 1ml of PBS and centrifuge for 3 min at 4,000XG. The
concentrator was transferred to a clean tube and centrifuge
at 1,000XG for 2 min to collect the concentrated sample.
The sample was diluted in serum physiologic.
PBMC culturing: Three healthy adult blood was
obtained from Acıbadem Labcell Cellular Therapy
Laboratory. Following the isolation of peripheral
mononuclear cells (PBMC) by overlaying blood on FicollPaque Plus (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden), the serially diluted GA-inactivated SARS-CoV-2
samples were incubated with the PBMCs for 48 h in T
cell medium (6% Human AB Serum and 1% Pen/Strep,
TexMACS Medium). ImmunoCult Human CD3/CD28 T
Cell Activator (STEMCELL Technologies Inc., Cambridge,
MA, USA) was used to stimulate the PBMCs as a positive
control for immunological activation.
Flow cytometry: Immune cell subtypes and their
activation levels were determined by Miltenyi MACS
Quant flow cytometry analysis using aCD3-PE, aCD19-
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PE.cy7, aCD56-FITC, aCD4-Viogreen, aCD8-Vioblue,
aCD25-APC and aCD107a-PE.cy5.5 (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany).
Interferon-gamma ELISA: Three human PBMC’s were
added to different inactivated SARS-CoV-2 virus diluted
to 5 different dilutions. After 48 h, supernatants were
collected and cytokine levels assed with Human IFNγ
ELISA Kit (Thermo Fisher Scientific ImmunoDiagnostics/
Phadia Austria GmbH, Vienna, Austria) according to the
manufacturer’s instructions. The 50 µL supernatants [test
samples, positive control (ImmunoCult-activated) and
negative control] were added into 450 µL sample diluents
(TexMACS) in tubes (1:10 serial dilution) and 50µL
diluents were added into wells. ELISA plate was measured
at 450 nm, and 550 nm using a Microplate Reader (BMG
Labtech GmbH, Offenburg, Germany).
2.6. Statistics
In the bar graphs, t-tests were performed using SPSS
Statistics software. No outliers were excluded in any of
the statistical tests and each data point represents an
independent measurement with three healthy adult donor
PBMCs. Bar plots report the mean and standard deviation
or the standard error of the mean. Threshold of significance
for all tests was set at P < 0.05.
3. Results
3.1. Propagation and genetic confirmation of SARSCoV-2 collected from COVID-19 patient
The SARS-CoV-2 including swab specimens collected from
COVID-19 diagnosed patients were quickly transferred
on the same day to the laboratory and incubated with Vero
cell in 96-well plate as mentioned in the method. Because
of low titer viruses, initial small size culture led to easy
recovery. Upon observation of the first cytopathic effect,
supernatant and the cells were transferred to a 24-well
plate with suspension form of Vero cell. Through 1 week,
the propagation of the virus was followed and increasing
cytopathic effects were recorded with respect to the
control Vero cell line without virus inoculum (Figure 1A).
As bovine coronavirus (B-CoV) is incubated with a bovine
kidney cell line (MDBK) (Matsumoto et al., 2005), we
wanted to test propagation of the SARS-CoV-2 with this
cell line. It showed a cytopathic effect faster than the Vero
cell line compared with control MDBK cell line without
virus inoculation (Figure 1B). To verify the presence of
the SARS-CoV-2 virus in the propagated samples, the
LAMP assay was conducted. After isolation of total RNA
and conversion to cDNA, LAMP assay was carried on a
real-time monitoring system with the detection of signals
coming from EvaGreen dye bound to amplicons (Figure
1C). For verification of the LAMP assay products, melt
curve analysis was added to the LAMP assay program,
and agarose gel electrophoresis was carried (Figures
1C and 1D). Samples giving internal control (actin) and
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SARS-Cov-2 amplicons were evaluated as positive (Figure
1D). Afterward, RT-PCR was performed with the LAMPpositive samples using SARS-CoV-2 Orf1ab and E gene
primers (Figure 1E). This data further confirmed the
SARS-CoV-2 isolation and propagation from 3 out of 6
patient isolates.
3.2. Transmission electron microscopy imaging and cytopathic effect (CPE) assay of SARS-CoV-2
Ultrastructural investigation of the SARS-CoV-2 was
performed with transmission electron microscopy (TEM).
TEM analysis showed that SARS-CoV-2 was located
within the cell line samples (Figure 2). The entry of SARSCoV-2 into the cell through caveolar structures has been
recognized in the sections. Ultrastructural organization
of the spike protein of SARS-CoV-2 was prominently
detected in the sections. Based on the ultrastructural data,

the propagation of the virus within the cell line has been
concluded (Figure 2). CPE assay is another way to show
virus infectivity (Guallart, 2015). Therefore, this assay was
performed on Vero and MDBK cell lines for isolated and
propagated virus. Although the literature (Harcourt et al.
2020) suggests that CPE formation was determined in 72
h, the CPE were observed in our experiments after 6 days
in both cell lines (Figure 3). The results confirmed our
methodological approach for the isolation and propagation
of SARS-CoV-2.
3.3. Immunological response of inactivated virus
PBMCs from healthy donors are a useful tool for
assessment of host response upon pathogen infection.
The cells can be stimulated by encountering SARS-CoV
and recruit immune cell subtypes such as natural killer T
(NKT), T, and B cells to the site of inflammation to give

Figure 1. SARS-CoV-2 propagation and genetic confirmation. A. Images of virus propagation in Vero cell line with respect to the
control Vero cell line without virus inoculation. B. Images of virus propagation in MDBK cell line along with the control MDBK cell
line that was not infected with virus. C. Graphics obtained from a representative LAMP assay carried on real time monitoring system
(Bio-Rad CFX96 Touch) with detection of EvaGreen fluorescent dye. Amplification curve (left) and melt peak (right) of LAMP assay
carried with internal control primers (actin) and SARS-CoV-2 primers. D. Agarose gel electrophoresis of the amplicons obtained after
LAMP assay shown in C. Products were run on 1% agarose gel, and stained with SYBR Safe (Thermo Fisher Scientific Inc.). Sample 1
to 6 are swap samples collected from COVID-19 patients. According to the results, sample 1, 3, and 4 were determined as SARS-CoV-2
positive. E. RT-PCR amplification curves of the LAMP-positive SARS-CoV-2 samples that were specifically amplified with SARS-CoV-2
Orf1ab and E gene primers.
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Figure 1. Continued.
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Figure 1. Continued.

Figure 2. Transmission electron microscopy images of SARS-CoV-2 propagation in Vero cell line. Arrows show the virus in the images
taken at different magnifications (200–100–50 nm).
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Figure 3. CPE assay of SARS-CoV-2 in A. Vero and B. MDBK cell lines with different virus titers. Images are taken in 6th day of the
assays.

an early adaptive immune response (He et al., 2006).
Therefore, we performed immunological assays to show
the impact of GA-inactivated SARS-CoV-2 on frequencies
and activation capacities of the cell subtypes. We
incubated healthy adult PBMCs with the inactivated virus
in a dose-dependent manner for 48 h and assessed their
proportions and expression level of activation markers
(CD25 and CD107a) using flow cytometry as shown in
Figure 4A. We determined an increase in the frequency
of CD3+ T cells, especially CD3+ CD4+ T helper cell,
except CD3+ CD8+ cytotoxic T cells at the highest
concentration of the virus (Figures 4B and 4C). On the
other hand, CD19+ B cell proportion has decreased upon
increasing the virus concentration, suggesting activation
of the immune cells (Figures 4B and 4C). Afterward, we
assessed activation of the T cells and NKT cells, and we
determined a significant upregulation of CD25 on CD3+
CD56+ NK T cells and an increase of CD25 level in CD3+
CD4+ T helper cell but not in CD3+ CD8+ cytotoxic T
cells (Figures 4B and 4C). However, we could not detect
the expression of a degranulation marker (CD107a) on the
cells (data not shown). These results led us to determine
another immunological stimulus marker (IFNg secretion)
using collected supernatant of the samples after 48 h.
We determined a significant increase inIFNg secretion
(Figure 5) using ELISA, which confirm the occurrence of
the immune response with chemically inactivated SARSCoV-2.
4. Discussion
Coronaviruses are enveloped RNA viruses that are widely
distributed among humans, other mammals, birds, which
cause respiratory, enteric, hepatic, and neurological
diseases (Weiss and Leibowitz, 2011; Masters and
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Perlman, 2013). After the first outbreaks of unexplained
pneumonia in Wuhan, China, a new coronavirus was
detected as a disease-causing agent in late 2019 and
January 2020 (Paraskevis et al., 2020) shows discordant
clustering with the Bat_SARS-like coronavirus sequences.
In April 2020, above 2 million cases have been reported
from 26 countries, including China (Hui et al., 2020). In
May 2020, above 5.5 million cases have been recorded.
The emergence of coronaviruses at regular intervals poses
an important threat to human health and the economy of
countries. Ironically, even after a decade of research on the
coronavirus, there are no licensed vaccines or therapeutic
agents to treat coronavirus infection. This emphasizes the
urgent need to develop effective vaccines to prevent future
outbreaks (Li et al., 2020).
In the process of specimen collection from patients and
transfer to the laboratory, the process should be started and
virus cultured immediately because lots of viruses became
inactivated. Therefore, we tested several transfer solutions
to safe infectious SARS-CoV-2 during transportation and
we decided FBS-free media is the best for protecting the
infectivity of the virus. Also, before culturing the cells
with the specimens, we wash the cells with FBS free media
to remove the excess of fetal bovine serum (Baer and
Kehn-Hall, 2014). Then, to propagate the virus, cells were
suspended with a virus media including 2% FBS, which
enabled much easier propagation of the virus than the
media including 10% FBS (Honda-Okubo et al., 2015).
Afterward, we tested Vero and MDBK cell lines to observe
cytopathic effects and it was determined that the spreading
of SARS-CoV-2 occurred in MDBK cells faster than in
Vero cells. Also, the cytopathic effect in the Vero cell line
was observed as a clump form while in the MDBK cell line
as a single cell base. CPE assay is a reliable way to show

TAŞTAN et al. / Turk J Biol

Figure 4: Stimulated immune response by GA-inactivated SARS-CoV-2. A. Flow cytometry plots that show immune cell subtypes
(CD19+ B, CD3+ CD4+ T helper, CD3+ CD8+ cytotoxic T, and CD3+ CD56+ Natural Killer T (NKT) cells) and their activation (with
aCD25 and aCD107a). EO, BY and RK are healthy human PBMCs. Also, SYT and RD are propagated SARS-CoV-2 samples from 2
COVID-19 patients. Graphs that show B. frequencies (linear graphs) and C. averages (bar graphs) of the immune cell subtypes and their
activation from 3 healthy donor peripheral blood mononuclear cells incubated with 2 different SARS-CoV-2 samples. P < 0.05, and NS:
Not significant.
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Figure 4. Continued.

Figure 5. IFNg secretion capacity of the stimulated PBMCs by SARS-CoV-2
in a dose-dependent manner. The graphs show IFNg secretion (pg/mL) upon
48 h incubation of the PBMCs with the virus (left graph) or with aCD3+aCD28
ImmunoCult (right graph). P < 0.05.

an infectious form of viruses. Therefore, in this study,
we performed CPE assay to see the infectivity of SARSCoV-2. During the CPE assay processes, we observed that
the monolayer form of Vero cells behaves more sensitive
than that of MDBK cells, which makes difficulties in the
setup of the assay. Because of low titer viruses, cytopathic
effect in Vero cells was determined later than as reported
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(Harcourt et al. 2020). Through 1 week, the propagation
of the virus was followed and increasing cytopathic effects
were recorded with respect to the control Vero cell line
without virus inoculum. Since control Vero cells were
comparatively confluent and intact with respect to the cells
inoculated with the virus, this CPE is thought to be due to
increase in virus infection. In the assay process, 90%–100%
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confluent Vero cells can be easily detached from the plate
while virus inoculation and covering with the agarose, that
may affect the determination of real virus-dependent CPE
formation; however, CPE assay with the MDBK cell line
was easy to perform, leading to safer result in CPE assay.
Therefore, our study suggests that the MDBK cell line is
efficient for CPE assay for virus titration and antiviral
drug screening. Furthermore, studies reported that CPE
formation time for SARS-CoV-2 was 72 h, however; in our
study, CPE formation was observed on the 6th day of the
infection, probably because of the virus low titer. Thus, we
suggest waiting for 10 days postinfection to determine the
titer of the virus by determining CPE.
Peripheral blood mononuclear cells are used to test
immune response stimulated by pathogens. To determine
immune cell activation through the proteins of inactivated
SARS-CoV-2, we incubated PBMCs with a chemicallyinactivated virus. The study shows us that T cells and
NKT cells can be stimulated with the virus and can be
assessed significantly in vitro setup. We also observed
a decrease in B cell population in higher concentrations
of the inoculums; probably activated and proliferated T
cells interfere with B cell proliferation (Stohl and Mayer,

1987). To further confirm the activation, we determined
IFNg secretion from the stimulated cells in PBMCs. These
preliminary results and other studies showing that SARSCoV antigens or synthetic peptides stimulated CD3+
T cells in human PBMC in vitro (Libraty et al., 2007; Li
et al., 2008) aiming to identify the immune correlates of
protection.
To conclude, this study can be referenced for
researchers who aimed to isolate and propagate SARSCoV-2 to work in molecular biology studies including
genomics, proteomics, and gene editings like CRISPR,
antisense peptide, and small interference RNA (siRNA)
therapies.
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